2018 Chrysler 300 Touring
3.6 L • V6 • 292 hp • RWD • AT
2C3CCAAG8JH308377
Sales history: 1
• $4,450Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
3.6 L • V6 • 292 hp • RWD • AT
Odometer
38,177 mi ≈ 61,440 km
Primary damage
Rear end
Docs
TX • Salvage
Extra
Auction
VIN
2C3CCAAG8JH308377
Lot number
84455295
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Lufkin, TX
Description
Fuel type
Gasoline
Body color
Burgundy
Body type
Sedan
Generation
LD
Trim
Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Chrysler models
2018 Chrysler 300 Touring • 3.6 L • V6 • 292 hp • RWD • Automatic • Copart Lot: 84455295 • VIN: 2C3CCAAG8JH308377
Find out more about this 2018 Chrysler 300 Touring, available at the Copart salvage car auction as lot #84455295 in Lufkin, TX. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 38,177 mi. This Burgundy Chrysler 300 Sedan is equipped with Gasoline 3.6 L engine, RWD drivetrain, Automatic transmission. Check the vehicle history report for 2C3CCAAG8JH308377 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
